Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19091610 | 0.93 | NMUR2 (0.35) | NMUR2TP53THRBALOX5PTGES | |
| SCHEMBL19082492 | 0.82 | MAPT (0.41) | NMUR2TP53THRBALOX5PTGES | |
| SCHEMBL19091475 | 0.81 | NMUR2 (0.38) | NMUR2TP53THRBALOX5PTGES | |
| SCHEMBL19082466 | 0.80 | NMUR2 (0.38) | NMUR2TP53THRBALOX5PTGES | |
| SCHEMBL19082490 | 0.77 | NMUR2 (0.43) | NMUR2ALOX5PTGESCYP2A6HPRT1 | |
| SCHEMBL19082498 | 0.77 | MEN1 (0.40) | THRBCYP2A6HPRT1CYP1A1CYP1A2 | |
| SCHEMBL19082495 | 0.76 | NMUR2 (0.37) | NMUR2TP53THRBPTGESCYP2A6 | |
| SCHEMBL19091030 | 0.76 | MAPT (0.44) | NMUR2NPC1HTT | |
| SCHEMBL19082471 | 0.75 | NMUR2 (0.46) | NMUR2ALOX5PTGESCYP2A6HPRT1 | |
| SCHEMBL19082477 | 0.75 | NMUR2 (0.38) | NMUR2PTGESCYP2A6HPRT1CYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | NMUR2 2800/4885TP53 3474/4885THRB 4466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.